Current epidemiology of septic shock: The CUB-Réa network

American Journal of Respiratory and Critical Care Medicine

Volumn 168, Issue 2, 2003, Pages 165-172

  Annane, Djillali ^a   Aegerter, Philippe ^b   Jars Guincestre, Marie Claude ^b   Guidet, Bertrand ^b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b NONE

Author keywords

Case control studies; Epidemiologic studies; Intensive care unit; Outcome; Sepsis

Indexed keywords

ADULT; AGED; ARTICLE; DATA BASE; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEPTIC SHOCK;

COMORBIDITY; DATABASES, FACTUAL; DRUG RESISTANCE, MULTIPLE; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RISK FACTORS; SHOCK, SEPTIC; SURVIVAL RATE;

EID: 0042165861     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2201087     Document Type: Article

References (31)

1. Bone RC. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991;114:332-333.
2. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
3. Center for Disease Control and Prevention. National Center for Health Statistics: annual summary of births, marriages, divorces and deaths, 1993. Mon Vital Stat Rep 1994;42:5-10.
4. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR. Epidemiology of sepsis syndrome in 8 academic medical center. JAMA 1997;278:234-240.
5. Angus D, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
6. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B for the French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA 1995;274:968-974.
7. Annane D, Sébille V, Troché G, Raphael JC, Gajdos P, Bellissant E. A three-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283:1038-1045.
8. Weinstein MP, Reller LB, Murphy JR, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II: clinical observations with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
9. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-214.
10. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
11. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-871.
12. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998;26:2078-2086.
13. Aegerter P, Auvert B, Buonamico G, Sznajder M, Beauchet A, Guider B, Legall JR, CUB-Réa. Mise en œuvre et évaluation d'une base de données commune aux services de réanimation d'Ile-de-France. Rev Epidémiol Santé Publique 1998;46:226-237.
14. Sznajder M, Leleu G, Buonamico G, Auvert B, Aegerter P, Merliere Y, Dutheil M, Guider B, LeGall JR. Estimation of direct cost and resource allocation in intensive care: correlation with Omega system. Intensive Care Med 1998;24:582-589.
15. McCabe WA, Jackson GG. Gram negative bacteriemia. Arch Intern Med 1962;110:847-855.
16. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
17. Catalogue des Actes Médicaux. Champs Beta et Omega. Fascicule Spécial, Ministère des Affaires Sociales de la Santé et de la Ville, Bulletin Officiel. Paris, France: Ministry of Health; 1995 No. 95-4bis.
18. Harell Jr FE. Regression modelling strategies. New York: Springer Verlag: 2001.
19. Hosmer DW, Lemeshow S. Confidence interval estimates of an index of quality performance based on logistic regression models. Star Med 1995;14:2161-2172.
20. Knaus WA, Harrell FE, Fischer CJ, Wagner DP, Opal SM, Sadoff JC, Draper EA, Walawander CA, Coboy K, Grasela TH. The clinical evaluation of new drugs for sepsis: a prospective study design based on survival analysis. JAMA 1993;270:1233-1241.
21. Pittet D, Thiévent B, Wenzel RP, Li N, Auckenthaler R, Suter PM. Bedside prediction of mortality from bacteremic sepsis: a dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996;153:684-693.
22. Vincent JL, Bihari D, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M. The prevalence of nosocomial infection in intensive care units in Europe: the results of the EPIC study. JAMA 1995;274:639-644.
23. Wenzel RP, Edmond MB. Managing antibiotic resistance. N Engl J Med 2000;343:1961-1963.
24. Raphael JC, Antony I, Bellissant E, Bonmarchand G, Cotting J, Fierobe L, Gouyon JB, Hasselmann M, Leleu G, Misset B, et al. Utilisation des cathécolamines au cours du choc septique (adultes-enfants). Réa Urg 1996;5:441-450.
25. Recommandations pour la Pratique Clinique: remplissage vasculaire au cours des hypovolémies relatives ou absolues. Réa Urg 1997;6:335-341.
26. Charbonneau P, Auriant I, Berger M, Calvat S, Fourrier F, Girardin G, Gobeaux RF, Lamer C, Lepape A, Leverve X, et al. Epuration extrarénale continue en réanimation (à l'exclusion de la dialyse péritonéale). Réa Urg 1998;7:174-182.
27. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia attributable mortality and morbidity. Am J Epidemiol 1989;129:1258-1267.
28. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-288.
29. Rello J, Jubert P, Valles J, Artigas A, Rué M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996;23:973-978.
30. Rello J, Rué M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS. Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 1997:25:1862-1867.
31. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients: SUPPORT investigators. JAMA 1996;276:889-897.